脱パイロジェン滅菌空バイアルの市場：タイプ、容量、エンドユーザー別-2025-2030年の世界予測

脱パイロジェン滅菌空バイアル市場は、2023年に7億9,779万米ドルと評価され、2024年には8億4,693万米ドルに達すると予測され、CAGR 6.67%で成長し、2030年には12億5,388万米ドルに達すると予測されています。

脱パイロジェン滅菌空バイアルの市場は、医薬品の製造において重要な役割を担っており、医薬品の保管と流通のために発熱性物質を含まない容器を提供していることが特徴です。これらのバイアルは注射薬の完全性を維持するために不可欠であり、患者の安全性を確保します。生物製剤やワクチン製造の増加により、バイオテクノロジーや製薬産業における需要が増加しており、その応用範囲は薬剤の調合、凍結乾燥、注射剤の保管を含みます。最終用途分野には病院、研究開発、製薬会社などが含まれ、無菌バイアルは医薬品開発と投与のさまざまな段階をサポートします。主な成長要因としては、慢性疾患の増加、注射薬の強力なパイプライン、政府の医療支出の増加、患者の安全性と薬効への関心の高まりなどが挙げられます。新たな開発機会は、化学的適合性を高めるために改良された材料を用いたバイアルの開発や、操作を合理化し汚染リスクを軽減する、すぐに使用できるプレフィラブルシステムの採用拡大にあります。しかし、市場は、高い製造コスト、厳しい規制基準、サプライヤーが通過しなければならない潜在的なサプライチェーンの制約などの課題に直面しています。市場関係者は、スマートパッケージングの先進性を追求し、IoT対応機能を統合してリアルタイムの品質保証を監視・確保すべきです。さらに、環境に優しく持続可能な素材を利用することで、環境に配慮したソリューションに対する需要の高まりに応えることができ、イノベーションの機が熟した分野となります。複雑な滅菌プロセスや規制遵守のハードルといった逆境は、業界関係者に継続的な技術革新と技術的・手続き的変化への適応を要求します。持続的成長のためには、利害関係者は材料科学の革新に焦点を当てた研究開発に投資し、精密性、拡張性、コンプライアンスニーズを満たすために生産プロセスを自動化すべきです。全体として、市場情勢は戦略的な事業適応と技術投資次第で成長の可能性を秘めたダイナミックなものです。

市場力学：急速に進化する脱パイロジェン滅菌空バイアル市場の主要市場インサイトを公開

脱パイロジェン滅菌空バイアル市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 製薬およびバイオテクノロジー業界からの需要の増加
  • ワクチン接種を推進する政府機関や民間団体のイニシアティブの高まり
• 市場抑制要因
  • ヘルスケアインフラの不足
• 市場機会
  • 滅菌・脱パイロジェン化技術の進歩
  • 脱パイロジェン滅菌空バイアルに特化した包装への注力の強化
• 市場の課題
  • 偽造品に関するリスク

ポーターのファイブフォース：脱パイロジェン滅菌空バイアル市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、脱パイロジェン滅菌空バイアル市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：脱パイロジェン滅菌空バイアル市場における外部からの影響の把握

外部マクロ環境要因は、脱パイロジェン滅菌空バイアル市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析脱パイロジェン滅菌空バイアル市場における競合情勢の把握

脱パイロジェン滅菌空バイアル市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス脱パイロジェン滅菌空バイアル市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、脱パイロジェン滅菌空バイアル市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨脱パイロジェン滅菌空バイアル市場における成功への道筋を描く

脱パイロジェン滅菌空バイアル市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 製薬業界およびバイオテクノロジー業界からの需要増加
    • ワクチン接種を推進する政府や民間団体の取り組みが増加
  • 抑制要因
    • ヘルスケアインフラの不足
  • 機会
    • 殺菌・脱パイロジェン技術の進歩
    • 脱パイロジェン滅菌空バイアルの特殊パッケージへの重点強化
  • 課題
    • 偽造品に伴うリスク
• 市場セグメンテーション分析
  • タイプ：コスト効率に優れたプラスチックバイアルの使用拡大
  • エンドユーザー：臨床調査における脱パイロジェン滅菌空バイアルの使用増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 脱パイロジェン滅菌空バイアルの市場：タイプ別

• ガラスバイアル
• プラスチックバイアル

第7章 脱パイロジェン滅菌空バイアルの市場：容量別

• 10mL
• 20mL
• 2mL
• 5mL

第8章 脱パイロジェン滅菌空バイアルの市場：エンドユーザー別

• ヘルスケア機関
• 製薬会社
• 調査・学術研究室

第9章 南北アメリカの脱パイロジェン滅菌空バイアルの市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の脱パイロジェン滅菌空バイアルの市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの脱パイロジェン滅菌空バイアルの市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ALKライフサイエンスソリューションズが脱パイロジェン滅菌空バイアルの販売でGalenovaと戦略的提携を締結
  • コーニングとSGDファーマが新たなガラス管工場で戦略的提携を結ぶ
• 戦略分析と提言

企業一覧

• Arab Pharmaceutical Glass Co.（APG）
• Bormioli Pharma
• Consol Glass
• Corning Inc.
• Gerresheimer AG
• Global Pharmatech Pvt. Ltd.
• Hindusthan National Glass & Industries Ltd.
• Nipro Corporation
• Piramal Glass
• SCHOTT AG
• SGD Pharma
• SGD S.A.S
• Shandong Pharmaceutical Glass Co., Ltd.
• Stevanato Group
• Thermo Fisher Scientific Inc.
• Triveni Polymers Pvt. Ltd.
• West Pharmaceutical Services, Inc.
• YPSOMED AG

LIST OF FIGURES

• FIGURE 1. DEPYROGENATED STERILE EMPTY VIALS MARKET RESEARCH PROCESS
• FIGURE 2. DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DEPYROGENATED STERILE EMPTY VIALS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DEPYROGENATED STERILE EMPTY VIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DEPYROGENATED STERILE EMPTY VIALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DEPYROGENATED STERILE EMPTY VIALS MARKET DYNAMICS
• TABLE 7. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 10ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 20ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 2ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 5ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH & ACADEMIC LABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 31. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 48. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. INDIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 51. INDIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 103. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. POLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 115. POLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. QATAR DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 118. QATAR DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. DEPYROGENATED STERILE EMPTY VIALS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. DEPYROGENATED STERILE EMPTY VIALS MARKET, FPNV POSITIONING MATRIX, 2023

The Depyrogenated Sterile Empty Vials Market was valued at USD 797.79 million in 2023, expected to reach USD 846.93 million in 2024, and is projected to grow at a CAGR of 6.67%, to USD 1,253.88 million by 2030.

The market for depyrogenated sterile empty vials is characterized by its critical role in pharmaceutical manufacturing, offering containers free from pyrogens for drug storage and distribution. These vials are essential in maintaining the integrity of injectable drugs, thus ensuring patient safety. With increasing demand in biotechnology and pharmaceutical industries, driven by the rise in biologics and vaccine production, the application scope encompasses drug compounding, lyophilization, and storage of injectable formulations. End-use sectors include hospitals, research labs, and pharmaceutical companies, where sterile vials support various stages of drug development and administration. Key growth influencers include rising incidences of chronic diseases, a robust pipeline of injectable drugs, escalating governmental health expenditure, and a heightened focus on patient safety and drug efficacy. Emerging opportunities lie in developing vials with improved materials for enhanced chemical compatibility and in the increasing adoption of ready-to-use and prefillable systems, which streamline operations and mitigate contamination risks. However, the market faces challenges such as high production costs, stringent regulatory standards, and potential supply chain constraints that suppliers must navigate. Market players should explore advancements in smart packaging and integrate IoT-enabled features to monitor and ensure real-time quality assurance. Moreover, utilizing eco-friendly and sustainable materials can cater to the growing demand for environmentally conscious solutions, presenting an area ripe for innovation. Adversities such as complex sterilization processes and regulatory compliance hurdles require industry players to innovate continually and adapt to technological and procedural changes. For sustained growth, stakeholders should invest in research and development focusing on material science innovations and automate production processes to meet precision, scalability, and compliance needs. Overall, the market exhibits a dynamic landscape ripe with potential for growth, contingent on strategic operational adaptations and technological investments.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Depyrogenated Sterile Empty Vials Market

The Depyrogenated Sterile Empty Vials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increased demand from pharmaceutical and biotechnology industries
  • Growing initiatives from government and private organizations to advance vaccination
• Market Restraints
  • Lack of healthcare infrastructure
• Market Opportunities
  • Advancements in sterilization and depyrogenation technologies
  • Enhanced Focus on Specialized Packaging for depyrogenated sterile empty vials
• Market Challenges
  • Risks associated with counterfeit products

Porter's Five Forces: A Strategic Tool for Navigating the Depyrogenated Sterile Empty Vials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Depyrogenated Sterile Empty Vials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Depyrogenated Sterile Empty Vials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Depyrogenated Sterile Empty Vials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Depyrogenated Sterile Empty Vials Market

A detailed market share analysis in the Depyrogenated Sterile Empty Vials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Depyrogenated Sterile Empty Vials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Depyrogenated Sterile Empty Vials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Depyrogenated Sterile Empty Vials Market

A strategic analysis of the Depyrogenated Sterile Empty Vials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Depyrogenated Sterile Empty Vials Market, highlighting leading vendors and their innovative profiles. These include Arab Pharmaceutical Glass Co. (APG), Bormioli Pharma, Consol Glass, Corning Inc., Gerresheimer AG, Global Pharmatech Pvt. Ltd., Hindusthan National Glass & Industries Ltd., Nipro Corporation, Piramal Glass, SCHOTT AG, SGD Pharma, SGD S.A.S, Shandong Pharmaceutical Glass Co., Ltd., Stevanato Group, Thermo Fisher Scientific Inc., Triveni Polymers Pvt. Ltd., West Pharmaceutical Services, Inc., and YPSOMED AG.

Market Segmentation & Coverage

This research report categorizes the Depyrogenated Sterile Empty Vials Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Glass Vials and Plastic Vials.
• Based on Capacity, market is studied across 10mL, 20mL, 2mL, and 5mL.
• Based on End-User, market is studied across Healthcare Institutions, Pharmaceutical Companies, and Research & Academic Labs.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increased demand from pharmaceutical and biotechnology industries
    • 5.1.1.2. Growing initiatives from government and private organizations to advance vaccination
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of healthcare infrastructure
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in sterilization and depyrogenation technologies
    • 5.1.3.2. Enhanced Focus on Specialized Packaging for depyrogenated sterile empty vials
  • 5.1.4. Challenges
    • 5.1.4.1. Risks associated with counterfeit products
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Expanding use of plastic vials due to their cost effective nature
  • 5.2.2. End-user: proliferating use of depyrogenated sterile empty vials in clinical research
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Depyrogenated Sterile Empty Vials Market, by Type

• 6.1. Introduction
• 6.2. Glass Vials
• 6.3. Plastic Vials

7. Depyrogenated Sterile Empty Vials Market, by Capacity

• 7.1. Introduction
• 7.2. 10mL
• 7.3. 20mL
• 7.4. 2mL
• 7.5. 5mL

8. Depyrogenated Sterile Empty Vials Market, by End-User

• 8.1. Introduction
• 8.2. Healthcare Institutions
• 8.3. Pharmaceutical Companies
• 8.4. Research & Academic Labs

9. Americas Depyrogenated Sterile Empty Vials Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Depyrogenated Sterile Empty Vials Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Depyrogenated Sterile Empty Vials Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. ALK Life Science Solutions Forms Strategic Partnership with Galenova for Distribution of Depyrogenated Sterile Empty Vials
  • 12.3.2. Corning and SGD Pharma Forge Strategic Alliance with New Glass Tubing Facility
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Arab Pharmaceutical Glass Co. (APG)
• 2. Bormioli Pharma
• 3. Consol Glass
• 4. Corning Inc.
• 5. Gerresheimer AG
• 6. Global Pharmatech Pvt. Ltd.
• 7. Hindusthan National Glass & Industries Ltd.
• 8. Nipro Corporation
• 9. Piramal Glass
• 10. SCHOTT AG
• 11. SGD Pharma
• 12. SGD S.A.S
• 13. Shandong Pharmaceutical Glass Co., Ltd.
• 14. Stevanato Group
• 15. Thermo Fisher Scientific Inc.
• 16. Triveni Polymers Pvt. Ltd.
• 17. West Pharmaceutical Services, Inc.
• 18. YPSOMED AG